Literature DB >> 21725246

Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes.

Maria Lahuerta1, Josue Lima, Batya Elul, Mie Okamura, Maria Fernanda Alvim, Harriet Nuwagaba-Biribonwoha, Deborah Horowitz, Rufino Fernandes, Americo Assan, Elaine J Abrams, Wafaa M El-Sadr, Denis Nash.   

Abstract

OBJECTIVE: To utilize routinely collected service delivery data from HIV care and treatment clinics in Mozambique to describe the patient population and programmatic outcomes from 2003 to 2009.
METHODS: Data from patient charts were entered into an electronic database at 28 clinics in 5 Mozambican provinces. Patients' characteristics at enrollment in HIV care and at antiretroviral therapy (ART) initiation were examined. We calculated a corrected 12-month mortality estimate using a recently developed nomogram for sub-Saharan African ART patients.
RESULTS: A total of 154,188 HIV-infected individuals (10,164 children <15 years old) were enrolled in HIV care services between 2003 and 2009. Of the 51,269 (36%) adults who started ART, 35% initiated ART with CD4 count <100 cells per microliter and 14.4% with World Health Organization stage IV. Just more than 10% (10.5%) of women were documented to be pregnant at enrollment. One-third of the 3,745 (37%) children who initiated ART were <2 years old, and 53% of those <5 years initiated ART severely immunosuppressed (CD4% <15%). Thirty-five percent of all children and 30% of those initiating ART met the definition of severe malnourishment (weight-for-age Z score <-3). Among those who initiated ART, the median estimated 12-month mortality rate across sites was 13.1% (interquartile range: 11.5%-16.0%) and 13.5% (interquartile range: 11.4%-17.4%) for adults and children, respectively.
CONCLUSIONS: A substantial number of HIV-infected patients have been enrolled in HIV care and initiated on ART, with many patients having advanced HIV disease. With the release of new guidelines for ART use for adults, pregnant women, and children, extensive efforts are needed to ensure more timely initiation of ART.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725246      PMCID: PMC3422887          DOI: 10.1097/QAI.0b013e31822ac0a9

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  20 in total

1.  Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.

Authors:  Linda-Gail Bekker; Landon Myer; Catherine Orrell; Steve Lawn; Robin Wood
Journal:  S Afr Med J       Date:  2006-04

2.  HIV prevention for a threatened continent: implementing positive prevention in Africa.

Authors:  Rebecca Bunnell; Jonathan Mermin; Kevin M De Cock
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

3.  Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration.

Authors:  Elise Arrivé; Daniel J Kyabayinze; Benoit Marquis; Nathan Tumwesigye; Mary-Pat Kieffer; Alain Azondekon; Louise Wemin; Patricia Fassinou; Marie-Louise Newell; Valériane Leroy; Elaine J Abrams; Mark Cotton; Andrew Boulle; Dorothy Mbori-Ngacha; François Dabis
Journal:  Int J Epidemiol       Date:  2007-11-12       Impact factor: 7.196

Review 4.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa.

Authors:  Elvin H Geng; Nneka Emenyonu; Mwebesa Bosco Bwana; David V Glidden; Jeffrey N Martin
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

6.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Authors:  Martin W G Brinkhof; François Dabis; Landon Myer; David R Bangsberg; Andrew Boulle; Denis Nash; Mauro Schechter; Christian Laurent; Olivia Keiser; Margaret May; Eduardo Sprinz; Matthias Egger; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

Review 7.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

8.  Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa.

Authors:  Isaac M Kigozi; Loren M Dobkin; Jeffrey N Martin; Elvin H Geng; Winnie Muyindike; Nneka I Emenyonu; David R Bangsberg; Judith A Hahn
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

9.  Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

Authors:  Denis Nash; Monica Katyal; Martin W G Brinkhof; Olivia Keiser; Margaret May; Rachael Hughes; Francois Dabis; Robin Wood; Eduardo Sprinz; Mauro Schechter; Matthias Egger
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

10.  Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Authors:  Martin W G Brinkhof; Mar Pujades-Rodriguez; Matthias Egger
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

View more
  27 in total

1.  Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.

Authors:  Zenebe Melaku; Matthew R Lamb; Chunhui Wang; Sileshi Lulseged; Tsigereda Gadisa; Solomon Ahmed; Zelalem Habtamu; Hailubeza Alemu; Tamrat Assefa; Elaine J Abrams
Journal:  BMC Public Health       Date:  2015-05-03       Impact factor: 3.295

2.  Transitioning HIV care and treatment programs in southern Africa to full local management.

Authors:  Sten H Vermund; Mohsin Sidat; Lori F Weil; José A Tique; Troy D Moon; Philip J Ciampa
Journal:  AIDS       Date:  2012-06-19       Impact factor: 4.177

Review 3.  HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?

Authors:  Emily P Hyle; Kogieleum Naidoo; Amanda E Su; Wafaa M El-Sadr; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

4.  Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries.

Authors:  Margaret L McNairy; Matthew R Lamb; Elaine J Abrams; Batya Elul; Ruben Sahabo; Mark P Hawken; Antonio Mussa; Ayele Zwede; Jessica Justman; Wafaa M El-Sadr
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

5.  Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya.

Authors:  Emily Koech; Chloe A Teasdale; Chunhui Wang; Ruby Fayorsey; Terezah Alwar; Irene N Mukui; Mark Hawken; Elaine J Abrams
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

Review 6.  The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?

Authors:  Maria Lahuerta; Frances Ue; Susie Hoffman; Batya Elul; Sarah Gorrell Kulkarni; Yingfeng Wu; Harriet Nuwagaba-Biribonwoha; Robert H Remien; Wafaa El Sadr; Denis Nash
Journal:  J Health Care Poor Underserved       Date:  2013-02

7.  Integration of HIV care and treatment in primary health care centers and patient retention in central Mozambique: a retrospective cohort study.

Authors:  Barrot H Lambdin; Mark A Micek; Kenneth Sherr; Sarah Gimbel; Marina Karagianis; Joseph Lara; Stephen S Gloyd; James Pfeiffer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

8.  Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.

Authors:  Margaret L McNairy; Matthew R Lamb; Rosalind J Carter; Ruby Fayorsey; Gilbert Tene; Vincent Mutabazi; Eduarda Gusmao; Millembe Panya; Mushin Sheriff; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

9.  Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi.

Authors:  Caryl Feldacker; Derek Johnson; Mina Hosseinipour; Sam Phiri; Hannock Tweya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique.

Authors:  Rituparna Pati; Maria Lahuerta; Batya Elul; Mie Okamura; Maria Fernanda Alvim; Bruce Schackman; Heejung Bang; Rufino Fernandes; Americo Assan; Josue Lima; Denis Nash
Journal:  J Int AIDS Soc       Date:  2013-06-10       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.